Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Animal models for seizures and epilepsy have played a fundamental role in advancing our understanding of basic mechanisms underlying ictogenesis and epileptogenesis and have been instrumental in the discovery and preclinical development of novel antiepileptic drugs (AEDs). However, there is growing concern that the efficacy of drug treatment of epilepsy has not substantially improved with the introduction of new AEDs, which, at least in part, may be due to the fact that the same simple screening models, i.e., the maximal electroshock seizure (MES) and s.c. pentylenetetrazole (PTZ) seizure tests, have been used as gatekeepers in AED discovery for >6 decades. It has been argued that these old models may identify only drugs that share characteristics with existing drugs, and are unlikely to have an effect on refractory epilepsies. Indeed, accumulating evidence with several novel AEDs, including levetiracetan, has shown that the MES and PTZ models do not identify all potential AEDs but instead may fail to discover compounds that have great potential efficacy but work through mechanisms not tested by these models. Awareness of the limitations of acute seizure models comes at a critical crossroad. Clearly, preclinical strategies of AED discovery and development need a conceptual shift that is moving away from using models that identify therapies for the symptomatic treatment of epilepsy to those that may be useful for identifying therapies that are more effective in the refractory population and that may ultimately lead to an effective cure in susceptible individuals by interfering with the processes underlying epilepsy. To realize this goal, the molecular mechanisms of the next generation of therapies must necessarily evolve to include targets that contribute to epileptogenesis and pharmacoresistance in relevant epilepsy models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kwan, P., Arzimanoglou, A., Berg, A. T., Brodie, M. J., Allen Hauser, W., Mathern, G., Moshé, S. L., Perucca, E., Wiebe, S., & French, J. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02397.x · Cited by 4,877
The neurobiology of antiepileptic drugs
Rogawski, M. A., & Löscher, W. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1430 · Cited by 1,239
Self-citationDrug resistance in brain diseases and the role of drug efflux transporters
Löscher, W., & Potschka, H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1728 · Cited by 900
Self-citationAntiepileptic Drug Development: II. Anticonvulsant Drug Screening
Krall, R. L., Penry, J. K., White, B. G., Kupferberg, H. J., & Swinyard, E. A. (1978) · Epilepsia · doi:10.1111/j.1528-1157.1978.tb04507.x · Cited by 823
Löscher, W., & Schmidt, D. (1988) · Epilepsy Research · doi:10.1016/0920-1211(88)90054-x · Cited by 806
Self-citationPharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy
Barton, M. E., Klein, B. D., Wolf, H. H., & Steve White, H. (2001) · Epilepsy Research · doi:10.1016/s0920-1211(01)00302-3 · Cited by 613
Models of Seizures and Epilepsy
(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-088554-1.x5000-2 · Cited by 561
Key factors in the discovery and development of new antiepileptic drugs
Bialer, M., & White, H. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2997 · Cited by 542
Löscher, W. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00073-6 · Cited by 509
Self-citationThe neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions
Rogawski, M. A., & Löscher, W. (2004) · Nature Medicine · doi:10.1038/nm1074 · Cited by 456
Self-citationLöscher, W., & Brandt, C. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003046 · Cited by 414
Self-citation(2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02744.x · Cited by 347
Development of new antiepileptic drugs: challenges, incentives, and recent advances
Perucca, E., French, J., & Bialer, M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70215-6 · Cited by 339
Preventing and treating posttraumatic seizures: The human experience
Temkin, N. R. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.02005.x · Cited by 329
Kindling: basic mechanisms and clinical validity
Sato, M., Racine, R. J., & McIntyre, D. C. (1990) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(90)90099-6 · Cited by 314
Experimental Models of Epilepsy: A Manual for the Laboratory Worker.
Wasterlain, C. (1973) · Archives of Neurology · doi:10.1001/archneur.1973.00490220092020 · Cited by 265
Modern management of epilepsy: A practical approach
Elger, C. E., & Schmidt, D. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.01.003 · Cited by 247
Animal models of intractable epilepsy
Löscher, W. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00035-x · Cited by 244
Self-citationLöscher, W., & Schmidt, D. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00607.x · Cited by 239
Self-citationProgress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (EILAT IX)
Bialer, M., Johannessen, S. I., Levy, R. H., Perucca, E., Tomson, T., & White, H. S. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2008.09.005 · Cited by 225
Löscher, W., & Schmidt, D. (1994) · Epilepsy Research · doi:10.1016/0920-1211(94)90012-4 · Cited by 221
Self-citationRefractory epilepsy: mechanisms and solutions
Kwan, P., & Brodie, M. J. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.3.397 · Cited by 179
Overview of the Current Animal Models for Human Seizure and Epileptic Disorders
Sarkisian, M. R. (2001) · Epilepsy & Behavior · doi:10.1006/ebeh.2001.0193 · Cited by 176
Models of Seizures and Epilepsy
Long, D. M. (2006) · Neurosurgery Quarterly · doi:10.1097/01.wnq.0000203019.86173.86 · Cited by 165
Glien, M., Brandt, C., Potschka, H., & Löscher, W. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.18101.x · Cited by 161
Self-citationStables, J. P., Bertram, E., Dudek, F. E., Holmes, G., Mathern, G., Pitkanen, A., & White, H. S. (2003) · Epilepsia · doi:10.1111/j.0013-9580.2003.32803.x · Cited by 160
Drug treatment of epilepsy in the century of the ILAE: The second 50 years, 1959–2009
Shorvon, S. D. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02042.x · Cited by 140
Models for Epilepsy and Epileptogenesis: Report from the NIH Workshop, Bethesda, Maryland
Stables, J. P., Bertram, E. H., White, H. S., Coulter, D. A., Dichter, M. A., Jacobs, M. P., Löscher, W., Lowenstein, D. H., Moshé, S. L., Noebels, J. L., et al. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.06702.x · Cited by 130
Self-citationCrino, P. B., Miyata, H., & Vinters, H. V. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00437.x · Cited by 128
Löscher, W., & Rundfeldt, C. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20238-5 · Cited by 126
Self-citationPostma, T., Krupp, E., Li, X. L., Post, R. M., & Weiss, S. R. B. (2000) · Epilepsia · doi:10.1111/j.1499-1654.2000.001514.x · Cited by 107
Brandt, C., Volk, H. A., & Löscher, W. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.16904.x · Cited by 93
Self-citationGenetically Defined Animal Models of Neurobehavioral Dysfunctions
Driscoll, P. (1992) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4899-6732-9 · Cited by 83
Encyclopedia of basic epilepsy research
Schwartzkroin, P. A. (2009) · Elsevier eBooks · Cited by 79
Animal Models of Epilepsy and Epileptic Seizures
Löscher, W. (1999) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60072-2_2 · Cited by 78
Self-citationKindling Increases the Sensitivity of Rats to Adverse Effects of Certain Antiepileptic Drugs
Hönack, D., & Löscher, W. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb01613.x · Cited by 77
Self-citationEncyclopedia of Basic Epilepsy Research
(2009) · Elsevier eBooks · doi:10.1016/c2009-1-03727-7 · Cited by 74
Use of epileptic animals for adverse effect testing
Klitgaard, H., Matagne, A., & Lamberty, Y. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00068-2 · Cited by 50
White, H. S., Smith-Yockman, M., SRIVASTAVA, A., & Wilcox, K. S. (2006) · Elsevier eBooks · doi:10.1016/b978-012088554-1/50046-3 · Cited by 37
Animal Models of Epilepsy: Methods and Innovations
(2009) · Neuromethods · doi:10.1007/978-1-60327-263-6 · Cited by 20
Kharatishvili, I., & Pitkänen, A. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32833749e4 · Cited by 16
Genetically defined animal models of neurobehavioral dysfunctions
van Abeelen, J. H. F. (1993) · Behavior Genetics · doi:10.1007/bf01067429 · Cited by 7
Cited by
Hippocampal GABAergic Inhibitory Interneurons
Pelkey, K. A., Chittajallu, R., Craig, M. T., Tricoire, L., Wester, J. C., & McBain, C. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00007.2017 · Cited by 889
Löscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019539 · Cited by 903
Self-citationNew avenues for anti-epileptic drug discovery and development
Löscher, W., Klitgaard, H., Twyman, R. E., & Schmidt, D. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4126 · Cited by 675
Self-citationAnimal models of epilepsy: use and limitations
Kandratavicius, L., Balista, P., Lopes-Aguiar, C., Ruggiero, R., Umeoka, E., Garcia-Cairasco, N., Bueno-Junior, L., & Leite, J. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s50371 · Cited by 467
Augustin, K., Khabbush, A., Williams, S., Eaton, S., Orford, M., Cross, J. H., Heales, S. J. R., Walker, M. C., & Williams, R. S. B. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30408-8 · Cited by 440
Metadata
- Authors
- Löscher, W.
- Venue
- Seizure
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 20
- Issue
- 5
- Pages
- 359-368
- ISSN
- 1059-1311 (ISSN-L)
- OpenAlex
- W2017398416
- Cited by
- 932
- References
- 42
- FWCI
- 22.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.